Rheumatology and musculoskeletal medicine.
Musculoskeletal disease accounts for a large proportion of a general practitioner's (GP's) workload. Proper management can not only improve quality of care, but also increase job satisfaction and reap rewards under the new contract. Osteoporosis creates a huge socioeconomic burden of disease and disability. Identifying high-risk groups in primary care and using preventative treatment can result in a substantial reduction in morbidity and mortality. GPs can help by presenting a unified lifestyle message, advising on fall prevention, and providing effective treatment; in particular, calcium and vitamin D for female nursing home residents. Osteoarthritis is eminently treatable in primary care with a number of management options for GPs, in addition to drug therapy. Glucosamine and chondroitin have few side effects and are worth recommending to patients with mild knee osteoarthritis. Rheumatoid arthritis can cause significant disability, which can be limited by early diagnosis, referral, and treatment. Severe refractory rheumatoid arthritis may warrant referral for consideration of biologic therapy. Assessment of the cardiovascular risk and possible use of statins in rheumatoid patients may reduce their cardiovascular mortality. GPs should aim to help patients to achieve optimum quality of life by using a holistic approach and by allowing maximum choice and control over their disease.
Davenport
Graham
G
The Surgery, The Green, Wrenbury, Nantwich, Cheshire. graham@wrenburygp.freeserve.co.uk
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005081:Exercise Therapy; D006801:Humans; D009140:Musculoskeletal Diseases / Q000517:prevention & control*; D010003:Osteoarthritis / Q000517:prevention & control; D010024:Osteoporosis / Q000517:prevention & control; D012219:Rheumatology / Q000639:trends*
D000894:Anti-Inflammatory Agents, Non-Steroidal